NCT06942624View on ClinicalTrials.gov

Phage Therapy for the Treatment of a Chronic Enterococcus Faecium Periprosthetic Joint Infection

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

May 31, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Periprosthetic Joint Infection
Interventions
BIOLOGICAL

Phage Therapy

Our phage is an investigational treatment for bacterial infections. Our lytic phage preparation was provided by Cytophage Technologies (CIP-200).

Trial Locations (1)

R2K 3S8

Concordia Hospital, Winnipeg

Sponsors
All Listed Sponsors
collaborator

Cytophage Technologies Inc.

UNKNOWN

collaborator

Ottawa Hospital Research Institute

OTHER

lead

Orthopaedic Innovation Centre

OTHER